Plate Nº 87 · recorded October 2, 2026
Health & Medicine ResearchReported finding
Diet and Exercise Reverse Early-Onset Type 2 Diabetes in Half of Cases
In a 96-person trial, an 800–900 kcal/day diet plus supervised exercise put 54% of under-45s with type 2 diabetes into remission at 24 weeks, versus 4% on usual care.
By Priya Raman6 min read1,168 words
In brief
- 54% of intervention participants achieved diabetes remission at 24 weeks, versus 4% of usual-care controls.
- The intervention combined an 800–900 kcal/day low-energy diet with supervised aerobic and resistance exercise.
- Intervention participants lost 7.5 kg more than controls after adjustment, including 6.6 kg more fat mass, with no severe adverse events.
A low-calorie diet paired with structured exercise put early-onset type 2 diabetes into remission for 54% of participants in a new clinical trial, compared with just 4% of those receiving usual care. After statistical adjustment, people in the intervention group were 21 times more likely to achieve remission than those in the control group.
The results come from the RESET for Remission study, led by Professor Kaberi Dasgupta of McGill University in Montreal, Canada, and Professor Thomas Yates of the University of Leicester, UK, with colleagues. The researchers presented their findings at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, held September 28 to October 2, and published them in The Lancet Regional Health Americas.
Why target early-onset diabetes?
Early-onset type 2 diabetes (EOT2D) is diagnosed in people under 45. It is a distinct and growing form of the disease that deteriorates faster than diabetes diagnosed later in life. People with EOT2D develop complications earlier and have shorter life expectancy than those with later-onset type 2 diabetes.
Low-energy diets can already push blood sugar below the diagnostic threshold for type 2 diabetes without medication — a state doctors call remission. Adding structured exercise may bring extra benefits: better fitness, preserved muscle mass, improved heart function, and lower insulin resistance, the phenomenon in which the body's cells respond poorly to the hormone that regulates blood sugar.
The researchers wanted to test whether combining the two approaches could arrest the rapid progression of this aggressive form of diabetes.
How the trial worked
Between September 24, 2021 and June 6, 2025, the team randomized 96 adults aged 18 to 45 with early-onset type 2 diabetes and obesity across three centers in England and Canada. None were on insulin therapy. Participants had an average age of 38 and an average body mass index of 35.2 kg/m². Of the 96, 86 (90%) attended final assessments.
The trial was randomized and open-label, meaning participants knew which group they were in, but the analysts assessing outcomes were blinded to group assignment.
The 50 participants in the intervention group followed a diet of 800–900 kcal/day, made up of 30% protein, 50% carbohydrate, and 20% fat. For the first two weeks, this meant total meal replacement with Optifast products. From weeks 3 to 12, participants continued the same caloric intake with more variety — Optifast in the UK and ProbiDiet in Canada — allowing one food-based meal per day. They were encouraged to drink at least 2 liters of calorie-free fluid daily and received a fiber-based laxative as needed.
Alongside the diet, participants did twice-weekly supervised exercise combining aerobic and resistance training, plus one independent session per week during the first 12 weeks. From weeks 13 to 24, they switched to a weight-maintenance diet with independent exercise. The 46 control participants received usual care.
Participants stopped all glucose- and blood pressure-lowering medication when they started the diet, unless they had albuminuria — protein in the urine that signals kidney damage.
The researchers defined remission as glycated hemoglobin (HbA1c, a measure of average blood sugar over roughly three months) below 6.5% (48 mmol/mol), while taking no glucose-lowering medication for at least 12 weeks.
Substantial weight loss, muscle preserved
At 24 weeks, 27 of 50 intervention participants (54%) were in remission, versus 2 of 46 controls (4%).
The intervention group started at a mean weight of 100.7 kg and lost an average of 8.4 kg, finishing at 92.3 kg. The control group started at 103.2 kg and lost just 1.2 kg on average, ending at 102.0 kg. After adjustment, the intervention group lost 7.5 kg more than controls, including 6.6 kg more fat mass.
The trial recorded no severe adverse events. Most intervention participants experienced at least one adverse event (43 of 50 versus 6 of 46 in the control group), mainly early effects of the low-energy diet such as constipation, headache, dizziness, and fatigue, all of which resolved.
"Our findings demonstrate the feasibility and efficacy of combining structured aerobic and resistance exercise with a low-energy diet in early-onset type 2 diabetes, supporting its potential to deliver substantial and holistic health and well-being benefits alongside diabetes remission," the authors say.
"Our remission rates are at the upper end of those previously reported in the literature for trials of similar duration, reinforcing the potential of structured lifestyle interventions to support clinically meaningful remission, while demonstrating for the first time that such effects can be achieved in a multi-ethnic population with early-onset type 2 diabetes through a combined low energy diet and structured exercise intervention."
Why muscle matters for the long term
The researchers highlight a well-known problem: most people regain some or all of the weight after any weight-loss program, including low-energy diets for diabetes remission. Weight loss driven by calorie restriction alone reduces both fat and fat-free mass — muscle, in plain terms. Some evidence suggests the weight that comes back is preferentially fat rather than muscle, leaving a net loss of muscle over time and raising the risk of sarcopenia, the age-related decline in muscle mass and strength.
"Our RESET for Remission study targeted muscle during the intensive weight loss phase through resistance training, and our findings indicate fat-free mass and muscle preservation is achievable with rapid weight loss," the authors say. "Preserving muscle during remission-oriented weight loss may have important implications for long-term metabolic health, physical function, and disease trajectory. This requires examination in a longer-term study."
Limitations and what comes next
The trial lasted only 24 weeks, so it cannot yet say whether remission persists, or whether muscle preservation translates into lasting metabolic benefits. The authors themselves call for longer-term evaluation in real-world settings, noting that weight regain is common. The open-label design, while necessary for this type of intervention, is also a limitation, though the endpoint assessment was blinded.
Still, the findings carry weight for a growing patient population. "By focusing specifically on early-onset type 2 diabetes, our trial addresses a growing clinical population, characterized by elevated cardiovascular disease risk, greater cumulative complication burden, and poor long-term outcomes," the authors conclude.
"In summary, RESET for Remission demonstrated that in early-onset type 2 diabetes, combining structured aerobic and resistance exercise with a low-calorie diet produces high remission rates, induces fat loss while preserving muscle mass, improves muscle quality and function, enhances cardiovascular health, and leads to meaningful improvements in patient-reported outcomes."
"As the prevalence of early-onset type 2 diabetes rises globally, our findings highlight an opportunity to re-evaluate treatment paradigms and support scalable implementation of integrated dietary and exercise interventions for remission. Our approach may be particularly valuable in those seeking or with potential for pregnancy. It warrants further evaluation in longer term studies in real-world settings."
via Medical Xpress (Source)
More from Priya Raman
Show full bio
Senior reporter covering industry trends and analytics at SciBeat.
57 articles
Nearby plates
- Very Low Carb Diets Show Health Benefits in Children with Type 1 Diabetes
- Maurius Becomes First Country to Reverse Its Type 2 Diabetes Epidemic
- Nearly 1 in 3 Diabetes Patients Face Kidney, Heart Disease or Death
- GLP-1 Diabetes Drugs Show Real-World Benefits in Young People
- Screening Children for Type 1 Diabetes Is Feasible, 8-Country Study Finds